Mono-arginine Cholesterol-based Small Lipid Nanoparticles as a Systemic siRNA Delivery Platform for Effective Cancer Therapy
Open Access
- 1 January 2016
- journal article
- Published by Ivyspring International Publisher in Theranostics
- Vol. 6 (2) , 192-203
Abstract
Although efforts have been made to develop a platform carrier for the delivery of RNAi therapeutics, systemic delivery of siRNA has shown only limited success in cancer therapy. Cationic lipid-based nanoparticles have been widely used for this purpose, but their toxicity and undesired liver uptake after systemic injection owing to their cationic surfaces have hampered further clinical translation. This study describes the development of neutral, small lipid nanoparticles (SLNPs) made of a nontoxic cationic cholesterol derivative, as a suitable carrier of systemic siRNA to treat cancers. The cationic cholesterol derivative, mono arginine-cholesterol (MA-Chol), was synthesized by directly attaching an arginine moiety to cholesterol via a cleavable ester bond. siRNA-loaded SLNPs (siRNA@SLNPs) were prepared using MA-Chol and a neutral helper lipid, dioleoyl phosphatidylethanolamine (DOPE), as major components and a small amount of PEGylated phospholipid mixed with siRNA. The resulting nanoparticles were less than ~50 nm in diameter with neutral zeta potential and much lower toxicity than typical cationic cholesterol (DC-Chol)-based lipid nanoparticles. SLNPs loaded with siRNA against kinesin spindle protein (siKSP@SLNPs) exhibited a high level of target gene knockdown in various cancer cell lines, as shown by measurement of KSP mRNA and cell death assays. Furthermore, systemic injection of siKSP@SLNPs into prostate tumor-bearing mice resulted in preferential accumulation of the delivered siRNA at the tumor site and significant inhibition of tumor growth, with little apparent toxicity, as shown by body weight measurements. These results suggest that these SLNPs may provide a systemic delivery platform for RNAi-based cancer therapy.Keywords
This publication has 46 references indexed in Scilit:
- The Role of the Helper Lipid on the DNA Transfection Efficiency of Lipopolyplex FormulationsScientific Reports, 2014
- Diffusion of Particles in the Extracellular Matrix: The Effect of Repulsive Electrostatic InteractionsBiophysical Journal, 2010
- Efficient Liposomal Nanocarrier‐mediated Oligodeoxynucleotide Delivery Involving Dual Use of a Cell‐Penetrating Peptide as a Packaging and Intracellular Delivery AgentMacromolecular Rapid Communications, 2010
- Lipid-based systemic delivery of siRNAAdvanced Drug Delivery Reviews, 2009
- A Novel Mechanism Is Involved in Cationic Lipid-Mediated Functional siRNA DeliveryMolecular Pharmaceutics, 2009
- Low toxicity of cationic lipid-based emulsion for gene transferBiomaterials, 2004
- Lipidic Carriers of siRNA: Differences in the Formulation, Cellular Uptake, and Delivery with Plasmid DNABiochemistry, 2004
- Growth hormone-releasing hormone (GHRH) antagonists inhibit the proliferation of androgen-dependent and -independent prostate cancersProceedings of the National Academy of Sciences, 2003
- New Cationic Liposomes for Gene Transfer into Mammalian Cells with High Efficiency and Low ToxicityBioconjugate Chemistry, 2001
- Oxygen Radical-Mediated Pulmonary Toxicity Induced by Some Cationic LiposomesPharmaceutical Research, 2000